THBS2 Promotes Prostate Cancer Malignancy via INHBA‐Dependent FAK/PI3K/AKT Signaling Activation
Analytical Cellular Pathology · 2026
DOI: 10.1155/ancp/3503659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Cellular Pathology, 2026. Verfasst von Yifeng Yao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Surgery, Tongxiang First People's Hospital (Tongxiang Hospital Affiliated to Hangzhou Medical College), No. 1918, Xiaochang Eas…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Thrombospondins, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2022 Zhejiang Province Health and Wellness Science and Technology Plan.
Abstract (Originalsprache)
Prostate cancer (PCa) is a leading malignancy among men, with a growing incidence and mortality rate worldwide. There is a pressing need to identify novel molecular biomarkers and therapeutic targets to improve prognosis and treatment strategies for PCa. We analyzed thrombospondin 2 (THBS2) expression patterns in PCa using The Cancer Genome Atlas (TCGA) datasets and validated findings in clinical tissues and cell lines. Functional assays, including Cell Counting Kit (CCK)‐8 proliferation, flow cytometry apoptosis, wound healing, and Transwell invasion, were performed on PCa cell lines with altered THBS2 expression. Bioinformatic analyses were conducted to explore THBS2‐related pathways, and protein interactions were examined via STRING and Western blot. THBS2 expression was significantly upregulated in PCa tissues and cell lines and correlated with advanced clinicopathological features and poor prognosis. Overexpression of THBS2 promoted PCa cell proliferation, migration, invasion, and epithelial‐mesenchymal transition (EMT), while inhibiting apoptosis. Mechanistically, THBS2 interacted with INHBA to activate the focal adhesion kinase (FAK)/PI3K/AKT signaling pathway, facilitating malignant progression. INHBA knockdown reversed the oncogenic effects of THBS2, indicating a synergistic interaction between THBS2 and INHBA in PCa pathogenesis. THBS2 acts as an oncogene in PCa by promoting proliferation, invasion, and EMT via the FAK/PI3K/AKT pathway in cooperation with INHBA. These findings highlight THBS2 as a promising biomarker for PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology Surgery, Tongxiang First People's Hospital (Tongxiang Hospital Affiliated to Hangzhou Medical College), No. 1918, Xiaochang East Road, Tongxiang, 314500, Zhejiang, China.
ORCID-Profile: Yifeng Yao, Yiyang Guo, Shoulei Liu, Yaojun Li, Shanmiao Chen
Förderung
- 2022 Zhejiang Province Health and Wellness Science and Technology Plan
Zitieren
APA
Yao, Y., Guo, Y., Liu, S., Li, Y., & Chen, S. (2026). THBS2 Promotes Prostate Cancer Malignancy via INHBA‐Dependent FAK/PI3K/AKT Signaling Activation. Analytical Cellular Pathology. https://doi.org/10.1155/ancp/3503659
Vancouver
Yao Y, Guo Y, Liu S, Li Y, Chen S. THBS2 Promotes Prostate Cancer Malignancy via INHBA‐Dependent FAK/PI3K/AKT Signaling Activation. Analytical Cellular Pathology. 2026. doi:10.1155/ancp/3503659
BibTeX
@article{Yao2026,
author = {Yao, Yifeng and Guo, Yiyang and Liu, Shoulei and Li, Yaojun and Chen, Shanmiao},
title = {THBS2 Promotes Prostate Cancer Malignancy via INHBA‐Dependent FAK/PI3K/AKT Signaling Activation},
journal = {Analytical Cellular Pathology},
year = {2026},
doi = {10.1155/ancp/3503659}
}
EUVIMED